In response to the requirements of Senate Bill 1827, passed by the 87th Texas Legislature in 2021, the Texas Comptroller of Public Accounts publishes statewide opioid settlement agreement records.
SB 1827 requires the state to maintain an account and a fund related to opioid abatement settlements. The account and fund are used to manage payments received by the state from settlements against opioid manufacturers, distributors, or other parties subject to violation of state or federal laws on the manufacture, marketing, distribution, or sale of opioids.
The Texas Opioid Abatement Fund Council was formed to ensure that money recovered through the joint efforts of the state and its political subdivisions through a statewide opioid settlement agreement is allocated fairly and spent to remediate the opioid crisis using efficient, cost-effective methods.
The council is administratively attached to the Texas Comptroller’s office, which provides the staff and facilities as necessary to assist the council in performing its duties.
Thank you for your interest in the Opioid Abatement Fund Council. Staff for the Opioid Abatement Fund Council is presently engaging in fact gathering about opioid abatement programs and strategies that may fit within the scope of the Council’s work. Organizations are encouraged to submit information about your organization’s opioid abatement programs and strategies for informational purposes only.
The Council is not currently accepting applications for grant funding.
Please be aware that the primary purpose of gathering information is to learn the industry and marketplace. Submitting information or discussing the programs and strategies offered by your organization will not constitute as applying for funds or demonstrate a commitment by the Council to fund potential grant application submissions.
Texas has participated in the following agreements with different companies to resolve legal claims against them for their role in the opioid crisis. Funding is dependent on the number of subdivisions or local governments that join the settlement agreements. The companies include opioid marketing consultant McKinsey, pharmaceutical companies Endo and Teva, opioid manufacturer Johnson & Johnson (“Janssen”) and pharmaceutical distributors AmerisourceBergen, Cardinal Health, and McKesson.
Below are the documents related to these agreements.